Authors: Dr Jacqueline Chen, Dermatology Resident; Dr Rachel Manifold, Dermatologist, Flinders Medical Center, Australia. Copy edited by Gus Mitchell. April 2022
Anogenital granulomatosis (AGG) is a rare chronicinflammatorygranulomatous disease of unknown aetiology. It is characterised by histological evidence of non-caseating granulomatous inflammation and can present with diffuse penile, scrotal, vulvar, or anoperineal swelling.
Who gets anogenital granulomatosis?
AGG is an uncommon condition that has been reported in both females and males of varying age groups from 1–79 years of age with the majority between 20–35 years of age. In 38% of cases, AGG can be associated with an underlying systemic condition such as Crohn disease or sarcoidosis. Associated Crohn disease may be symptomatically silent, or there may be a lag of several years between the appearance of genital swelling or lesions, and objective evidence of associated inflammatory bowel disease.
What causes anogenital granulomatosis?
The cause of anogenital granulomatosis is unknown. It is characterised by granulomatous genital or anoperineal inflammation and lymphoedema. Intralymphaticgranulomas have been noted to cause partial or complete occlusion of the drainage of lymphatics, subsequently causing lymphoedema.
What are the clinical features of anogenital granulomatosis?
Most commonly presents as:
Chronic penile, scrotal, vulval, or anoperineal swelling
With or without erythema.
Other clinical features include:
Fissures, perianal tags and ulcers
Difficulties with urinary flow and sexual intercourse.
What are the complications of anogenital granulomatosis?
Lymphoedema and granulomas containing epithelioid cells, multinucleatedgiant cells, and lymphocytes.
Further investigations, such as serum angiotensin-converting enzyme (ACE) and chest radiograph to exclude sarcoidosis can be conducted. Colonoscopy and faecal calprotectin to exclude Chron disease should be considered for patients with gastrointestinal symptoms.
There are reported cases of Crohn disease developing years after symptoms started, therefore long-term follow-up is warranted.
What is the differential diagnosis for anogenital granulomatosis?
Biological treatment such as tumournecrosis factor-α (TNF-α) inhibitors including infliximab and adalimumab, as some reports show symptom improvement
Surgical treatment can be considered if refractory cases affect micturition, sexual intercourse, and discomfort.
Bibliography
Alexakis C, Gordon K, et al. Anogenital granulomatosis and Chron’s disease: a case series of males presenting with genital lymphoedema. J Chrons Colitis 2017; 11(4):454–9. DOI:10.1093/ecco-jcc/jjw173. Journal
Honap S, Meade S, Spencer A, et al. Anogenital Crohn's disease and granulomatosis: a systematic review of epidemiology, clinical manifestations, and treatment. J Crohns Colitis. 2021;jjab211. doi:10.1093/ecco-jcc/jjab211. Journal
Saracino A, Gordon K, Ffolkes L, Mortimer P. Intralymphatic granulomas in lymphedema secondary to anogenital granulomatosis. Aust J Dermatol. 2012;54(3). DOI: 10.1111/j.1440-0960.2012.00923.x. Journal
Van de Scheur MR, Van der Waal RIF, van der Waal TJ Stoff, Van Deventer SJH. Anogenital granulomatosis: the counterpart of orofacial granulomatosis. JEADV 2003; 27: 184–9. DOI: 10.1046/j.1468-3083.2003.00573.x. Journal
Villar M, Petit G, Gurra A, Vanaclocha F. Anogenital granulomatosis. Actas Dermo-Sifiliogr. 2012; 103(1):76–9. DOI: 10.1016/j.adengl.2011.05.007. PubMed